Search research articles
Contact Us
Filters
Showing results (31-40 of 386) with videos related to
Page
of 39
Sort By:
Biochemical and Biophysical Research Communications
|
June 30, 1993
The cyclic-AMP antagonist adenosine-3',5'-cyclic monophosphosphorothioate, RP-isomer inhibits parathyroid hormone induced bone resorption, in vitro
O Ljunggren, S Ljunghall
Biochemistry and Molecular Biology International
|
February 1, 1996
Growth hormone and insulin-like growth factor-I do not activate identical genes in normal human osteoblasts
H Melhus, S Ljunghall
Journal of Electrocardiology
|
April 1, 1994
Serum calcium and the ECG in patients with primary hyperparathyroidism
L Lind, S Ljunghall
Blood Pressure
|
March 1, 1993
Hypertension, primary hyperparathyroidism and the parathyroid hypertensive factor
L Lind, S Ljunghall
British Medical Journal
|
December 6, 1975
Letter: Renal stones and coronary heart disease
S Ljunghall, H Hedstrand
Urologia Internationalis
|
January 1, 1983
Normalization of hypercalcaemia of primary hyperparathyroidism by treatment with methallenestril, a synthetic oestrogen with low oestrogenicity
G Herbai, S Ljunghall
Experimental and Clinical Endocrinology
|
January 1, 1994
Blood pressure reaction during the intraoperative and early postoperative periods in patients with primary hyperparathyroidism
L Lind, S Ljunghall
Nordisk Medicin
|
January 1, 1991
[Primary hyperparathyroidism--a frequently overlooked cause of psychological symptoms]
S Ljunghall, C Joborn
British Medical Journal
|
February 26, 1977
Serum phosphate inversely related to blood pressure
S Ljunghall, H Hedstrand
Acta Orthopaedica Scandinavica
|
June 1, 1979
A case of Albright's syndrome treated with calcitonin
A Hjelmstedt, S Ljunghall
Page
of 39
Search research articles
Search
Showing results (31-40 of 386) with videos related to
Sort By:
Page
of 39
Biochemical and Biophysical Research Communications
|
June 30, 1993
The cyclic-AMP antagonist adenosine-3',5'-cyclic monophosphosphorothioate, RP-isomer inhibits parathyroid hormone induced bone resorption, in vitro
O Ljunggren, S Ljunghall
Biochemistry and Molecular Biology International
|
February 1, 1996
Growth hormone and insulin-like growth factor-I do not activate identical genes in normal human osteoblasts
H Melhus, S Ljunghall
Journal of Electrocardiology
|
April 1, 1994
Serum calcium and the ECG in patients with primary hyperparathyroidism
L Lind, S Ljunghall
Blood Pressure
|
March 1, 1993
Hypertension, primary hyperparathyroidism and the parathyroid hypertensive factor
L Lind, S Ljunghall
British Medical Journal
|
December 6, 1975
Letter: Renal stones and coronary heart disease
S Ljunghall, H Hedstrand
Urologia Internationalis
|
January 1, 1983
Normalization of hypercalcaemia of primary hyperparathyroidism by treatment with methallenestril, a synthetic oestrogen with low oestrogenicity
G Herbai, S Ljunghall
Experimental and Clinical Endocrinology
|
January 1, 1994
Blood pressure reaction during the intraoperative and early postoperative periods in patients with primary hyperparathyroidism
L Lind, S Ljunghall
Nordisk Medicin
|
January 1, 1991
[Primary hyperparathyroidism--a frequently overlooked cause of psychological symptoms]
S Ljunghall, C Joborn
British Medical Journal
|
February 26, 1977
Serum phosphate inversely related to blood pressure
S Ljunghall, H Hedstrand
Acta Orthopaedica Scandinavica
|
June 1, 1979
A case of Albright's syndrome treated with calcitonin
A Hjelmstedt, S Ljunghall
Page
of 39